Treatment Of Flbrodysplasia Ossificans
Progressiva: Case Report And Literature Review
Khalid
Al-Ruhaimi, BDS, MSc, Dr. Med Dent, FICS,
A. Lewis Nwoku, MD, DMD, FICS
College of Dentistry, King Saud University, P.O. Box
60169, Riyadh 11545, Saudi Arabia
A case of a
patient with fibrodysplasia ossificans progressiva (FOP) is presented. Based on
the knowledge that all known treatment modalities for this disease do not offer
any cure, we advocate that surgical and/or adjunctive medical treatment would
be selective until the nature of the disease is better understood.
Fibrodysplasia ossificans progressiva (FOP) or myositis
ossificans progressiva is a rare connective tissue disorder that has eluded
both medical understanding and treatment. Considerable interest in this anomaly
has developed since it had been originally described by Patin1 in 1692. The occurrence of the disease is
sporadic but it may be inherited as an autosomal dominant trait in some of the
cases.2 FOP
is characterized by progressive ossification of the connective tissue that can
be detected radiographically. A soft tissue lesion that subsequently ossifies
increases with the incidence of trauma,3 including surgical trauma. The unrelenting
progres-sive calcification of skeletal muscles decreases the mobility of the
affected child making him almost like a living pillar of stone. Therapy has
been experimental due to lack of knowledge on the basic defects in FOP which
causes normal fibrous tissue to become ectopic cartilage and bone.
Al this time there is no generally accepted medical
treatment. Surgery has been shown to be not only ineffective due to progressive
nature of the disease but it aggravates aberrant reossification at the site of
operation, causing further loss of function and immobilization.2,3 In recent times isotretinoin (13-cis-retinoic
acid) has been utilized, but has been found ineffective in preventing the
progression of the disease.4 The
purpose of this paper is to report one case, highlight the error in any
decision for surgical interventions, and to caution overly ambitious surgeons.
Case Report
A 28-year-old man with FOP attended the outpatient Oral
and Maxillofacial Clinic of the Dental
College, King
Saud University,
Riyadh with a
history of trismus. His food was restricted to liquid diet. Physical
examination revealed an emaciated, pleasant, intelligent man in no acute
distress. His mouth opening was limited to 1 mm due to ossification of
ligaments of the left temporomandibular joint and masticatory muscles of that
side [Fig. 1 ]. There was minimal range of motion of his neck, trunk, left
shoulder and chest. The involvement of the cervical paravertebral musculature
coupled with the immobility of the shoulder, thoracic cage and lumbar region
forced him to adapt a characteristic posture of scoliosis in senility [Fig. 2J.
He gave a history of stiffness of his trunk after a fall
at 10 years of age. He claimed that immobilization of his jaw occurred after a
trauma received on the left side of his neck one year before attending our clinic.
Previous operation has been performed at the age of 15 years in his left
shoulder to relieve a stiff joint but reossification recurred after 6 months.
He was receiving no medication. Family history was unremarkable.
The patient was informed that as yet there is no method of
curing or treating his disorder. He was advised to keep on a fully nutritious
liquid diet and avoid trauma whenever possible.
The patient came back to our clinic six months later after
receiving surgical mobilization of his jaw at another hospital. He reported
that there was a temporary mobility of his jaws and that he could open his
mouth in the first three months after the operation, but thereafter gradual
decrease in mouth opening occurred. On examination there was complete relapse
of his jaw movement which had recurred after 3 months of surgery.
Despite the rarity of FOP, its
striking appearance has prompted many researchers to study the diagnostic
features and trials of treatment of the disease. The origin and stimulus of the
disease are unknown. However, trauma, including surgical trauma, can often
provoke onset of the lesion leading to joint immobilization by bony bridges.
Reossification 2-6 months after surgical removal of the original ossified mass
has been reported.5,6 It has been noted that
biopsies in patients with FOP are not recommended for two reasons. First, the
histologic appearance may be confusing and may lead to misdiagnosis such as
fibrosarcoma or fibromatosis. Second, it
has been recognized that trauma including surgical operations may aggravate FOP
and induce more rapid ossification.6,7 Numerous forms of medical treatment have been
attempted. These include high-dose etidronate dis-odium therapy.8,9 Diaphosphonates delay mineralization of newly
formed bone matrix but this delay is neither definite nor consistent. Dis-odium
EDTA has been used unsuccessfully to reduce ectopic mineralization.10 Therapy with retinoic acid has also been
attempted to inhibit proliferation of fibrous tissue to chondro-osseous tissue.
Both of the reported patients had recurrence of their ectopic ossification
within two months of treatment.4
So far, all known modalities of treatment of FOP have been
empirical, and these forms of medical therapy, as well as surgical
intervention, have not been beneficial. There is, as yet, no effective therapy
available to cure the disease.
In the light of what is known today about FOP, any
surgical intervention, or indeed iatrogenic insult is not recommended.
Over-zealous surgeons offer only temporary relief to their patients, but bring
them greater despair and despondency. In this situation, one must be modest and
admits that there is, as in a few other diseases, no known cure yet.
We are, therefore, of the opinion that attempts at
surgical intervention and/or medical therapy would be better avoided until such
time as the stimulus and origin of the disease is better understood.
- Palin G.
In: Lettres choisis de fue M. Guy Patin. Letter of August 27, 1648, to AF. Cologne: P. du Laurens,
1692;5:28.
-
Dixon TF, Mulligan L, Nassim R, Steveson FH. Myositis ossificans
progressiva: report of a case which ACTH and cortisone failed to prevent
reossification after excision of ectopic bone. J Bone Surg 1954;36:445-49.
-
Smith R.
Myositis ossificans progressiva: A review of current problems. Sem Arthritics
Rheum 1 975;4:369-80.
-
Crofford
LJ, Brahim JS, Zasloff MA, Marini JC. Failure of surgery and isotretinoin to
relieve jaw immobilization in fibrodysplasia ossificans progressiva. J Oral
Maxillofac Surg 1990;48:204-08.
-
Smith R,
Russell GG; Woods CG. Myositis ossificans progressiva:
clinical features of eight patients and their response to treatment. J Bone
Joint Surg 1976;58:48-57.
-
Connor |M,
Evans DAP. Fibrodysplasia ossificans progressiva. The clinical features and
natural history of 34 patients. J Bone Joint Surg 1972;64:76.
-
Rogers JG, Geho WB. Fibrodysplasia ossificans progressiva: A survey of
forty-two cases. J Bone Joint Surg 1979;61A:909.
-
Wood BJ,
Robinson GC. Drug-induced bone changes in myositis ossificans progressiva.
Pediatr Radiol I976;5:40-43.
-
Rogers JG, Dorst JP, Geho WB. Use and complications of high-dose
disodium etidronate therapy fibrodysplasia ossificans progressiva. J Pediatr
1977;91:1011-14.
-
Hentzer B, Jacobsen HH, Asboe-Hansen C, Fibrodysplasia (myositis)
ossificans progressiva, treated with disodium etidronate. Clin Radiol
1978;29:69-75.
|